The PAWS Pet Company's 10K is Imminent; Delay Caused by Complexity Due to Recent Merger
17 April 2014 - 11:03PM
Company Expects Filing as Early as Today
PraXsyn Name Change Has Been Filed With the State of Illinois
and Soon to be Filed With FINRA
The PAWS Pet Company, Inc. (OTCQB:PAWS), announces
that its 10K filing has been delayed by some unforeseen issues due
to its recent merger. "Although we pushed to the extreme to get the
10K filed on time, last minute issues and our desire to be
completely accurate and fully complete, got the better of us," said
Dan Wiesel, CEO of The PAWS Pet Company.
The company expects to have the 10K filed as early as today.
On the bright side, we can announce that we have filed the
paperwork with the State of Illinois to change the company's name
to PraXsyn, Inc. and will be using the new name on the 10K filing.
We will also be filing name change paperwork shortly with
FINRA.
Our goal at the new PraXsyn to is provide medical practitioners
with products and services to help them help their patients. Our
Mesa Pharmacy division currently provides doctors with an
alternative to oral pain medications. Mesa focuses on providing
custom compounded non-narcotic, transdermal topical pain
medications that are marketed to industrial health physicians and
clinics. Mesa has developed a series of topical ointments, in
different strengths, that provide the pain relief doctors seek.
About PraXsyn, Inc.
PraXsyn, Inc. is dedicated to providing medical practitioners
with medications and services for their patients. We currently
formulate transdermal creams and ointments in our compounding
pharmacy, Mesa Pharmacy. These are geared to patients suffering
from long-term pain associated with work place related injuries. In
the near future, we will be instituting our Point of Care/In-Office
Dispensing Program, and our In-Office Toxicology Testing. As the
medical industry changes, PraXsyn will be there to provide
different delivery systems.
For additional information go to www.praxsyn.com

Company Contact: ir@praxsyn.com
Forward-Looking Statements
Certain statements made in this press release are
forward-looking in nature (within the meaning of the Private
Securities Litigation Reform Act of 1995) and, accordingly, are
subject to risks and uncertainties. The actual results may differ
materially from those described or contemplated and consequently,
you should not rely on these forward-looking statements as
predictions of future events. Certain of these risks and
uncertainties are discussed in the reports we filed with the
SEC.
Praxsyn (CE) (USOTC:PXYN)
Historical Stock Chart
From Jan 2025 to Feb 2025
Praxsyn (CE) (USOTC:PXYN)
Historical Stock Chart
From Feb 2024 to Feb 2025
